- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Sharps Technology Inc: Sharps Regains Nasdaq Listing Compliance | 71 | GlobeNewswire (Europe) | NEW YORK, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: "STSS" and "STSSW") ("Sharps"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class... ► Artikel lesen | |
| SHARPS TECHNOLOGY Aktie jetzt für 0€ handeln | |||||
| 14.11. | Sharps Technology Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 07.11. | Sharps Technology Inc. - 8-K, Current Report | - | SEC Filings | ||
| 14.10. | Sharps Technology to effect 1-for-22 reverse stock split | 1 | Seeking Alpha | ||
| 14.10. | Sharps Technology Inc: Sharps Technology, Inc. Announces Stockholders' Approval of Reverse Stock Split Ratio and Effective Date | 70 | GlobeNewswire (Europe) | NEW YORK, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: "STSS" and "STSSW") ("Sharps"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class... ► Artikel lesen | |
| 10.10. | Aktionäre von Sharps Technology stimmen Aktienzusammenlegung zu | 1 | Investing.com Deutsch | ||
| 10.10. | Sharps Technology shareholders approve reverse stock split | 1 | Investing.com | ||
| 10.10. | Sharps Technology Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 30.09. | Sharps Technology Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 30.09. | Sharps Technology Inc: Sharps Technology, Inc. Reminds Shareholders to Vote Before Important Shareholder Meeting on October 7, 2024 | 75 | GlobeNewswire (Europe) | NEW YORK, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: STSS) (the "Company"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class... ► Artikel lesen | |
| 27.09. | TechMediaBreaks - Sharps Technology Inc. (NASDAQ: STSS) Secures $3.5 Million Bridge Financing | 2 | iNVEZZ.com | ||
| 27.09. | Aegis Capital Corp. Acted as Exclusive Placement Agent on a $3.5 Million Bridge Financing for Sharps Technology, Inc. | 284 | ACCESSWIRE | NEW YORK, NY / ACCESSWIRE / September 27, 2024 / Aegis Capital Corp. acted as Exclusive Placement Agent on a $3.5 Million Bridge Financing for Sharps Technology, Inc. (NASDAQ:STSS).About Sharps Technology... ► Artikel lesen | |
| 24.09. | Sharps Technology Inc: Sharps Technology, Inc. Closes $3.5 Million Bridge Financing | 3 | GlobeNewswire (USA) | ||
| 23.09. | Aktie von Sharps Technology erreicht 52-Wochen-Tief bei 0,17 US-Dollar | 1 | Investing.com Deutsch | ||
| 23.09. | Sharps Technology stock hits 52-week low at $0.17 | 1 | Investing.com | ||
| 23.09. | Sharps Technology Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 23.09. | Sharps Technology sichert sich Überbrückungskredit in Höhe von 3,5 Millionen US-Dollar | 1 | Investing.com Deutsch | ||
| 23.09. | Sharps Technology secures $3.5 million bridge loan | 2 | Investing.com | ||
| 23.09. | Sharps Technology gets $3.5M bridge loan financing | 1 | Seeking Alpha | ||
| 23.09. | Sharps Technology Inc: Sharps Technology, Inc. Announces $3.5 Million Bridge Financing | 1 | GlobeNewswire (USA) |
Seite:
1 2 3 Weiter >>
53 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| STRATEC | 27,700 | -0,89 % | Kurs von Stratec bricht ein (28,80 €) | Zu den großen Verlierern an der Börse zählt heute der Anteilsschein von Stratec . Der Titel verliert deutlich an Wert. Ein Minus von 6,65 Prozent zeigt die Kurstafel für das Wertpapier von Stratec an.... ► Artikel lesen | |
| EMEIS | 5,705 | +1,44 % | emeis: Upturn in Performance Confirmed in Third-Quarter 2024 | Revenue up +8.3%, occupancy rate up +2.6 points
Regulatory News:
emeis (Paris:EMEIS):
Growth in all core activities and in all geographical areas (revenue and occupancy rate)
Solid... ► Artikel lesen | |
| VERU | 0,586 | -1,76 % | Veru Inc.: Veru Reaches Full Enrollment for Phase 2b QUALITY Clinical Study of Enobosarm for Obesity and Reports Fiscal 2024 Third Quarter Financial Results | --Phase 2b QUALITY study of enobosarm in combination with semaglutide (Wegovy®*) exceeds targeted full enrollment of >150 patients-- --Topline data for primary endpoint of lean body mass expected... ► Artikel lesen | |
| NANO-X IMAGING | 5,890 | 0,00 % | Nano-X Imaging LTD.: Nanox Receives FDA Clearance for HealthCCSng V2.0, Upgraded Version of Advanced AI Cardiac Solution Empowering Physicians in Assessment of Coronary Artery Calcium | HealthCCSng V2.0 introduces additional 'zero calcium' categorization of coronary artery calcium (CAC) and generates a numerical calcium score with corresponding CAC detection category output Marks... ► Artikel lesen | |
| BUTTERFLY NETWORK | 3,325 | 0,00 % | BFLY-Aktie erreicht 52-Wochen-Hoch bei 2,95 US-Dollar | ||
| GOODRX | 4,310 | 0,00 % | GoodRx Holdings one of the most undervalued stocks, Leerink says | ||
| TALKSPACE | 3,160 | 0,00 % | Espresa Partners with Talkspace to Boost Employee Well-Being with Accessible Mental Health Benefits | Espresa has partnered with Talkspace to expand mental health support for employees. Through Espresa's platform, clients now have access to Talkspace's 5,000+ licensed therapists, offering secure, on-demand... ► Artikel lesen | |
| CARMAT | 1,190 | -1,00 % | CARMAT's Aeson Artificial Heart Is Gradually Becoming a Reference Solution for Bridge to Transplant in Europe | Milestone of 30 heart transplants post Aeson® support, passed Strong interest in Aeson® from the medical community: more than 100 European experts will share their experience at the first... ► Artikel lesen | |
| JOINT CORP | 11,310 | 0,00 % | JYNT's Q3 Earnings Meet Estimates Amid Higher Costs, Shares Dip 3% | ||
| MIMEDX | 9,070 | 0,00 % | MIMEDX GROUP, INC. - 8-K, Current Report | ||
| HYPERFINE | 0,900 | 0,00 % | Hyperfine, Inc. Reports Third Quarter 2024 Financial Results | GUILFORD, Connecticut, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 92,70 | 0,00 % | Looking Into PROCEPT BioRobotics' Recent Short Interest | ||
| PROGYNY | 13,980 | 0,00 % | Barclays Lowers Progyny (NASDAQ:PGNY) Price Target to $17.00 | ||
| BIOMERICA | 0,320 | 0,00 % | Biomerica, Inc.: Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements | IRVINE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a leading global provider of advanced medical diagnostics, announced that it has been granted an additional 180-day... ► Artikel lesen | |
| ATRICURE | 36,030 | 0,00 % | Pre-market Movers: ASP Isotopes, NerdWallet, Reddit, AtriCure, Qorvo | OLATHE (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.05 A.M. ET).In the Green ASP Isotopes Inc. (ASPI) is up over 44% at $8.33.
NerdWallet... ► Artikel lesen |
SHARPS TECHNOLOGY INC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 3,220 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SHARPS TECHNOLOGY INC finden Sie auf Wallstreet Online.
